MassDevice.com +5 | The top 5 medtech stories for September 23, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Medtronic escapes Infuse lawsuits involving fugitive Ohio doc Medtronic yesterday escaped hundreds of lawsuits filed over the allegedly off-label use of its controversial bone-growth product, Infuse, by a Cincinnati doctor who has since fled to Pakistan. Infuse consists of a collagen sponge that’s soaked in a bone-growth protein called recombinant human bone morphogenetic protein-2 and implanted in the spine within a metal device called the LT-Cage. The FDA approved Infuse in 2002 for use in single-level anterior lumbar interbody fusions (other dental and trauma indications followed). Read more 4. Draper Labs plans human study of neural implants Draper Laboratories is reportedly planning for the 1st human study of its neural implants for amputees to begin in late 2016 or early 2017. This follows Phase I findings that demonstrated Draper’s wireless electronics package for its implantable devices work effectively by achieving a high bandwidth communication capacity of 20 megabits per second, relaying information quickly and efficiently. Read more 3. Staar Surgical...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news